Home/Filings/4/0001638599-20-000916
4//SEC Filing

Ianchulev Tsontcho 4

Accession 0001638599-20-000916

CIK 0001682639other

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:07 PM ET

Size

17.6 KB

Accession

0001638599-20-000916

Insider Transaction Report

Form 4
Period: 2020-11-20
Transactions
  • Other

    Common Stock, par value $.0001

    2020-11-20453,3330 total(indirect: By LLC)
Holdings
  • Class B Warrant

    Exercise: $2.72From: 2020-03-24Exp: 2025-03-24Common Stock (61,823 underlying)
    61,823
  • Stock Option (right to buy)

    Exercise: $3.11Exp: 2029-08-16Common Stock (183,703 underlying)
    183,703
  • Stock Option (right to buy)

    (indirect: By Private Medical Equity, Inc.)
    Exercise: $1.24From: 2015-03-23Exp: 2025-03-23Common Stock (140,000 underlying)
    140,000
  • Common Stock, par value $.0001

    (indirect: By Private Medical Equity, Inc.)
    606,667
  • Class A Warrant

    Exercise: $2.27From: 2020-03-24Exp: 2021-03-24Common Stock (41,216 underlying)
    41,216
  • Common Stock, par value $.0001

    508,679
  • Stock Option (right to buy)

    Exercise: $6.20Exp: 2028-07-24Common Stock (124,210 underlying)
    124,210
  • Stock Option (right to buy)

    Exercise: $2.72Exp: 2030-06-02Common Stock (285,255 underlying)
    285,255
  • Common Stock, par value $.0001

    (indirect: By Trust)
    6,000
  • Stock Option (right to buy)

    Exercise: $1.95Exp: 2027-07-07Common Stock (267,370 underlying)
    267,370
Footnotes (8)
  • [F1]On November 20, 2020, PME Investor Services Eyenovia, LLC, of which the reporting person is a manager, distributed its holdings of the Issuer's common stock in-kind and on a pro rata basis to its members.
  • [F2]The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The exercise price per share of the Issuer's common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events.
  • [F4]The number of shares of Issuer common stock issuable upon exercise of the Class A and Class B Warrants is subject to adjustment for stock splits, stock dividends and similar corporate events.
  • [F5]The option became exercisable as to 11,140 shares on August 7, 2017 and became exercisable in equal 11,140 share amounts on each of the 35 one-month anniversaries thereafter.
  • [F6]This option is fully vested.
  • [F7]One-third of the option became exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
  • [F8]One-third of this option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001728916

Filing Metadata

Form type
4
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 4:07 PM ET
Size
17.6 KB